Differentiating Erythropoietic Activity Profiles in Acute Myeloblastic Leukemia and Acute Lymphoblastic Leukemia
INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY · 27.07.2026 · 32 (3) · 321-326
DOI: 10.24293/ijcpml.v32i3.2598 ↗Kurz gefasst
Fachartikel in der Zeitschrift INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY, online erschienen am 27.07.2026. Verfasst von Azma Rosida und 6 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Acute leukemia, comprising acute myeloblastic leukemia (AML) and acute lymphoblastic leukemia (ALL), severely disrupts hematopoiesis, frequently manifesting as profound anemia. This study aims to investigate thedifferences in erythropoietic activity between adult AML and ALL patients by analyzing advanced hematological and reticulocyte parameters, including red blood cell count (RBC), hemoglobin (Hb), mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), and immature reticulocyte fraction (IRF). A retrospective, cross-sectional study was conducted using medical records of adult patients diagnosed between January 2021 and July 2024 at Ulin General Hospital, Banjarmasin, Indonesia. Data from 45 AML and 45 ALL adult patients were evaluated. Following normality screening via the Kolmogorov-Smirnov test, comparative analysis was performed using the independent t-test or Mann-Whitney U test. Significant differences were observed in red blood cell (RBC) counts (p = 0.048) and medium fluorescence ratio (MFR) (p = 0.002) between the AML and ALL groups, indicating varied erythropoietic responses. These variations may stem from distinct bone marrow compensatory mechanisms, disease-specific microenvironmental alterations, and diverse patient demographic profiles. Our findings highlight advanced reticulocyte kinetics as a potential tool for monitoring erythropoietic status, which could optimize therapeutic strategies for leukemia-associated anemia. Future large-scale investigations are recommended to confirm these preliminary findings.
Zitieren
APA
Rosida, A., Raharjo, A. T. D., Fatimah, J. N., Ulfah, F., Prenggono, M. D., Hendriyono, F. X., & Devi, W. R. (2026). Differentiating Erythropoietic Activity Profiles in Acute Myeloblastic Leukemia and Acute Lymphoblastic Leukemia. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY, 32(3), 321-326. https://doi.org/10.24293/ijcpml.v32i3.2598
Vancouver
Rosida A, Raharjo ATD, Fatimah JN, Ulfah F, Prenggono MD, Hendriyono FX, et al. Differentiating Erythropoietic Activity Profiles in Acute Myeloblastic Leukemia and Acute Lymphoblastic Leukemia. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 2026;32(3):321-326. doi:10.24293/ijcpml.v32i3.2598
BibTeX
@article{Rosida2026,
author = {Rosida, Azma and Raharjo, Agatha Theodora Desvita and Fatimah, Jasmine Nisa and Ulfah, Fahrina and Prenggono, Mohammad Darwin and Hendriyono, Franciscus Xaverius and Devi, Wivina Riza},
title = {Differentiating Erythropoietic Activity Profiles in Acute Myeloblastic Leukemia and Acute Lymphoblastic Leukemia},
journal = {INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY},
year = {2026},
volume = {32},
number = {3},
pages = {321--326},
doi = {10.24293/ijcpml.v32i3.2598}
}
EUVIMED